www rich9 art
Stock market today: Wall Street rallies ahead of Christmas
Of the many things I admire, near the top would be the art of the witty insult or the elegant put-down. It takes restraint, imagination and a certain clever bent of mind. We’re not all capable of it but those who are I would call special. After all, repartee is not easy. To do it stylishly requires effort and skill. So, as the year ends and we prepare for the next, let me share a few gems. Now some of the best put-downs are attributed to Churchill vis-à-vis Lady Astor and George Bernard Shaw. But they’re too well-known to bear repetition. Let me, instead, choose others as searing but less familiar. First, the put-the-famous-in-their-place comment. Noel Coward once met Edna Ferber at the Algonquin Hotel in New York. “Miss Ferber, you look almost like a man.” She promptly shot back: “And so do you, Mr Coward.” Whilst Howard Hughes thus described Clark Gable: “His ears make him look like a taxi cab with both doors open.” And David Susskind had this to say of Elizabeth Taylor’s Cleopatra: “Overweight, overbosomed, overpaid and under-talented, she set the acting profession back a decade.” My favourite is the scorching reply when you don’t want to accept an invitation. Invited by David Frost to dinner, Peter Cook responded: “Hang on, I’ll just check my diary... oh dear, I find I’m watching television that night.” And this is what David Niven said when Errol Flynn stood him up yet again: “You can count on Errol Flynn. He’ll always let you down.” Of course, there’s nothing like being rude with such panache that your target will probably end up smiling. Heinrich Heine, the poet, said: “I bequeath all my property to my wife on condition that she re-marry immediately. Then there will be at least one man to regret my death.” Or Disraeli on his great political rival Gladstone: “The difference between a misfortune and a calamity is this: If Gladstone fell into the Thames, it would be a misfortune. But if someone dragged him out again, that would be a calamity.” Again, my favourite is the most succinct one. “How can they tell?” asked Dorothy Parker on being told US President Calvin Coolidge was dead. In fact, Parker’s wit could be excruciatingly sharp. Of the famous actress Katharine Hepburn, she hissed: “She ran the gamut of human emotions all the way from A to B.” Put-downs are often not about individuals but general comments about countries or about life itself. Jeremy Clarkson once said: “Life is never so bad that Germany is better.” Isaac Asimov commented on the sort of people who irritate all of us: “People who go around claiming they know everything are very annoying for those of us who do.” WH Auden said of academics: “A professor is one who talks in someone else’s sleep.” Whilst Nancy Astor thus pronounced on marriage: “I married beneath me – all women do.” Women, for some reason, have often been the subject — not just victims — of put-downs. “Being a woman is a terribly difficult trade since it consists principally of dealings with men,” said Joseph Conrad, who wrote Heart of Darkness . The German philosopher Friedrich Nietzsche claimed, “Woman was God’s second mistake.” The first was Adam. And JB Priestley, I presume a misogynist, maintained that “Marriage is a long, dull meal with pudding as the first course.” I wonder how many of you agree? Amongst the most piercing are the put-downs authors use for their rivals. William Faulkner, who didn’t like Ernest Hemingway, said this of him: “He has never been known to use a word that might send a reader to the dictionary.” In turn, Hemingway riposted: “Does he really think big emotions come from big words?” I’ll leave you with a put-down we could all profitably use, though remember Churchill said it first of Attlee: “A modest man with much to be modest about.” Incidentally, this sort makes the best friends. Happy New Year. Karan Thapar is the author of Devil’s Advocate: The Untold Story.The views expressed are personal
Is Keeping Your Home Organized More Challenging Than Your 9-To-5 Job?Ireland blamed Northern Ireland Office for ‘damaging leaks’, records show
Ex-Tesco worker's 11 brutal truths they wish they could tell customersFormula 1 expands grid to add General Motors' Cadillac brand and new American team for 2026 season
New York, New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Americans love a great deal, and this has created the phenomena of Black Friday and Cyber Monday. Across multiple categories, deals are offered in goods and services over the US Thanksgiving weekend period. But for the Travel industry, moving ahead of either of these days is Travel Tuesday. Data Scientists at Fareportal, the New York-based travel technology company behind leading online travel agencies CheapOair and OneTravel report that in 2023, sales for Black Friday, Cyber Monday and Travel Tuesday saw double digit increases as compared to the previous week. However, Travel Tuesday performance outpaced the three-day average by a noteworthy 59%. The CheapOair and OneTravel teams expect this trend to carry over to this year’s activity. Many airlines will be offering the traveling public great deals on airline tickets over the Black Friday, Cyber Monday, Travel Tuesday sales period. Among these CheapOair points to American Airlines, United Airlines, Air France, LATAM Airlines, Volaris, Avianca, Frontier Airlines, Spirit Airlines, Ryanair, JetBlue, Air India, Emirates, Qatar Airways, Etihad Airways, Aer Lingus, Norse, French Bee, TAP Air Portugal, Philippine Airlines, Fiji Airways, China Airlines, LOT Polish, Singapore Airlines, NEOS and Sky Airlines as just a small sample of the multiple domestic and international carriers that will be making special offers available to the travel buyer. An article published in early November on the CheapOair Miles Away blog delves into the topic and compares Black Friday to Travel Tuesday through the lens of the overall shopping experience, and that of the travel purchase. Also take a moment to read this Cyber Monday Travel Guide published November 22 nd on CheapOair Miles Away. Sandeep Gill, Fareportal Interim President, comments, “Each year we are thrilled to be able to offer our customers our very best deals in available airfares. As consumer awareness of Travel Tuesday has increased over the years, so too has the airlines’ focus on providing exciting deals over the Thanksgiving weekend period. We expect to be very busy serving our customers’ needs over the next week, and through the busy holiday air travel season!” Consumers can visit CheapOair or OneTravel to sign up for Fare Alerts and get help with air travel inspiration, planning, and booking. About CheapOair CheapOair is an online travel agency that specializes in providing cheap flights and great last-minute flight deals for travelers worldwide. Consumers can book online, on mobile apps, by phone or live chat. Part of the Fareportal family of travel brands, CheapOair bridges the gap between an online travel agency and a traditional agency with certified travel agents available to help find great deals on flight tickets to global destinations on over 500 airlines, a million lodgings, and 100s of car rental companies. Follow CheapOair on Facebook , Twitter , and Instagram to learn how to travel the world for less. About Fareportal Fareportal is New York-based travel technology company powering a next generation travel concierge service. Utilizing its innovative technology and company-owned and operated global contact centers, Fareportal has built strong industry partnerships providing customers access to over 500 airlines, a million lodgings, and hundreds of car rental companies around the globe. With a portfolio of consumer travel brands including CheapOair and OneTravel Fareportal enables consumers to book online, on mobile apps for iOS and Android, by phone, or live chat. Fareportal provides its airline partners with access to a broad customer base that books international and domestic flight, lodging, and other travel and add-on ancillaries.5 Lessons To Learn From Southern Europe’s Climate Change Strategies
The 25-year-old Sweden international took his goal tally for the season to 12 in the 3-0 Boxing Day win over Aston Villa at St James’ Park, 10 of them in his last 10 Premier League games, after a challenging start to the new campaign. Isak managed 25 goals in a black and white shirt last season to further justify the club record £63million the club paid to bring him to Tyneside from Real Sociedad during the summer of 2022, but as delighted as he is with his big-money signing, head coach Howe is confident there is even more to come. Murph 🔗 Alex Isak Different game. Same link up. 💪 pic.twitter.com/OMhZf7dtKZ — Newcastle United (@NUFC) December 27, 2024 Asked where the former AIK Solna frontman currently ranks in world football, he said: “My biggest thing with Alex is I am evaluating his game on a daily and weekly basis and I just want to try to push him for more. “Everyone else can say where he is in the pecking order of world football. His game is in a good place at the moment. “My job is to not sit back and appreciate that, my job is to try and find areas he can improve, push him towards that and never stop pushing him. He has all the ingredients in there. Football never stops evolving and changing and he has to evolve with it. “There is a lot more to come from him. Our job is to help him deliver that. “Of course the main responsibility is for Alex to keep his focus, ignore the plaudits and keep helping the team, not be selfish. It is about Newcastle and he plays his part.” It is no coincidence that Newcastle have prospered as Isak has rediscovered his best form, and they will head for Manchester United – where they have won only once in the top flight since 1972 – on Monday evening looking for a fifth successive win in all competitions. He has scored in each of the last five league games having grown into the mantle of the Magpies’ main man, a role performed with such distinction in the past by the likes of Jackie Milburn, Malcolm Macdonald and Alan Shearer, and he has done so with the minimum of fuss. Asked about his character, Howe said: “He is calm, cool – he is what you see on the pitch. “He doesn’t get overly emotional, which for a striker is a great quality because that coolness you see and calmness in front of goal is part of his personality, part of what he is. He seems to have an extra half a second when other players don’t. “With Alex, the beauty of his attitude is that he wants to improve. We give him information and he is responsive. He is not a closed shop. “He is in no way thinking he has arrived at a certain place. He knows he has to keep adding to his game. The challenge is great for him to keep scoring freely as he is now.”Top 10 stories of 2024: Greeley soft launches Real-Time Information CenterToo many people want to be social-media influencers
Daily Post Nigeria NPFL: Eguma appointed new Enyimba head coach Home News Politics Metro Entertainment Sport Sport NPFL: Eguma appointed new Enyimba head coach Published on December 28, 2024 By Mike Oyebola Enyimba has announced the appointment of Stanley Eguma as their new head coach, DAILY POST reports. Eguma will take charge of the nine-time Nigeria Premier Football League, NPFL, champions following the sacking of Yemi Olanrewaju. Olanrewaju was fired on Saturday following the Aba giant’s poor result in recent outings. The People’s Elephants are winless in eight consecutive matches in all competitions. It is their longest winless streak in 20 years. Eguma last managed one-time NPFL champion, Rivers United. Related Topics: Eguma enyimba NPFL Don't Miss NPFL summons Nasarawa, Rivers United over crowd trouble You may like NPFL summons Nasarawa, Rivers United over crowd trouble NPFL: Niger Tornadoes will overcome Rangers in Minna – Okoro NPFL: Odigie linked with Akwa United coaching job NPFL: Pillars coach reveals plan for El-kanemi Warriors clash NPFL: Finidi demands improved performance from players against Plateau United NPFL: Shooting Stars battle ready for Kwara United Advertise About Us Contact Us Privacy-Policy Terms Copyright © Daily Post Media LtdOcean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
MELBOURNE, Australia and INDIANAPOLIS , Dec. 30, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix®[1], 89 Zr- girentuximab) kidney cancer imaging[2]. TLX250-CDx is an investigational PET[3] drug product for the non-invasive diagnosis and characterisation of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in the U.S., further building on Telix’s successful urology imaging franchise. The FDA is expected to advise the PDUFA[4] goal date following the 60-day administrative review of the application. Kevin Richardson , Chief Executive Officer, Precision Medicine at Telix, stated, “We are pleased to be progressing the BLA for TLX250-CDx, which has been granted Breakthrough designation, and may therefore be eligible for priority review. Telix continues to target a full U.S. commercial launch in 2025 addressing a major unmet medical need for patients with suspected ccRCC.” About TLX250-CDx TLX250-CDx (Zircaix® 1 ) is an investigational PET agent that is under development for the diagnosis and characterisation of ccRCC. Telix’s pivotal Phase III ZIRCON trial (ClinicalTrials.gov ID: NCT03849118 ) evaluating TLX250-CDx in 300 patients, of whom 284 were evaluable, met all primary and secondary endpoints, including showing 86% sensitivity and 87% specificity and a 93% positive-predictive value for ccRCC across three independent radiology readers[5]. Telix believes this demonstrated the ability of TLX250-CDx to reliably detect the clear cell phenotype and provide an accurate, non-invasive method for diagnosing and characterising ccRCC. Confidence intervals exceeded expectations amongst all three readers, showing evidence of high accuracy and consistency of interpretation. About Telix Pharmaceuticals Limited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia , with international operations in the United States , Europe ( Belgium and Switzerland ), and Japan . Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX). Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[6], by the Australian Therapeutic Goods Administration (TGA) [7], and by Health Canada [8] . No other Telix product has received a marketing authorisation in any jurisdiction. Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn . Telix Investor Relations Ms. Kyahn Williamson Telix Pharmaceuticals Limited SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board. Legal Notices You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States . The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix® and Zircaix® 1 names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. View original content to download multimedia: https://www.prnewswire.com/apac/news-releases/telix-files-tlx250-cdx-zircaix-bla-for-kidney-cancer-imaging-302339972.html SOURCE Telix Pharmaceuticals LimitedMyscha Theriault: Geocaching is the free vacation activity that’s hiding in plain sight
Innofactor Plc Stock Exchange Release, on November 25, 2024, at 20:05 Finnish time Innofactor postpones the Annual General Meeting of 2025 to be held on June 25, 2025. Contrary to the previously announced preliminary date, the Annual General Meeting will not be held on April 23, 2025. On November 25, 2024, Onni Bidco Oy announced that it has decided to exercise its redemption right pursuant to the Finnish Companies Act and to redeem all the shares held by all other remaining shareholders in Innofactor. Espoo, November 25, 2024 INNOFACTOR PLC Eija Theis, General Counsel Additional information: Eija Theis, General Counsel Innofactor Plc Tel. +358 44 343 4278 eija.theis@innofactor.com Distribution: NASDAQ Helsinki Main media www.innofactor.com Innofactor Innofactor is the leading driver of the modern digital organization in the Nordic Countries for its about 1,000 customers in commercial and public sector. Innofactor has the widest solution offering and leading know-how in the Microsoft ecosystem in the Nordics. Innofactor has about 600 enthusiastic and motivated top specialists in Finland, Sweden, Denmark and Norway. The Innofactor Plc share is listed in the technology section of the main list of NASDAQ Helsinki Oy. www.innofactor.com #ModernDigitalOrganization #PeopleFirst #CreatingSmiles #BeTheRealYouJoseph-Aukuso Suaalii could be available to play against Ireland on Saturday after the Wallabies’ medical staff ruled out any structural damage to his wrist after the Test rookie appeared to injure it in Sunday’s 14-point defeat against Scotland. Suaalii hurt his right wrist after tackling Scotland captain Sione Tuipulotu with only 30 minutes gone in the game. The centre immediately left the field after losing function in his arm and experiencing severe pain but is recovering well enough to take part in training this week in Dublin ahead of the Wallabies’ final Test of the year. Suaalii was only starting his second game for the Wallabies, after his impressive debut against England and an 18-minute appearance off the bench against Wales. The early loss of Suaalii made life even more difficult for the Wallabies, with three tries conceded in his absence. Second-rower Jeremy Williams is also available for selection for the Wallabies against Ireland after illness ruled him out of the matchday squad just before kick-off against Scotland. Williams’ return is timely given Will Skelton has returned to his club La Rochelle in France, due to the Ireland Test falling outside World Rugby’s designated international window. The Wallabies are the chosen opponents for the Irish Rugby Football Union’s 150th-anniversary celebrations and will hope for an improved performance after being so clinically dispatched in Edinburgh. Wallabies prop Allan Alaalatoa revealed the team’s bitter disappointment after the game in Edinburgh at losing the opportunity of playing for a Grand Slam on Saturday. “The feeling in there was tough, like no one said a word, you could see the body language of the boys straight after the game,” Alaalatoa said. “Because there was real belief, that we could win the Grand Slam and that came through the way that we prepared throughout the whole year and the way that the whole squad has contributed. “So that’s footy I guess, and it wasn’t our night ... so we push on to the next goal, which is to beat Ireland in Dublin.” Joseph-Aukuso Suaalii on the ground after getting injured. Credit: Getty Images The Wallabies conceded 14 penalties in Edinburgh, their second-highest total under coach Joe Schmidt, only bettered by 15 against South Africa in their first game of the Rugby Championship in July. Alaalatoa experienced not only the frustration of the team’s disciplinary errors, but also the failure of their defensive system, after the team missed 34 tackles. “Especially around that first half, it was probably just the quality of our tackle, just finishing off those tackles ... our discipline, which are things that we can control,” Alaalatoa said. “So that’s the message for us as leaders, and through the coaches as well, that the momentum we gave them was through things that we can control.” Like the Wallabies, Ireland have two victories and one defeat in November, winning against Fiji and Argentina and losing to New Zealand. Alaalatoa is aware of the scale of the challenge in Dublin, but is motivated by upsetting the form book. Loading “(It’s) very important, Ireland obviously have been number one in the world for a while now, or number one and number two, and they’ve been a quality side for years, so we know how important this is, but I think more so for ourselves as well,” Alaalatoa said. “To come away three (wins) and one (defeat) will be awesome for our group. So, yeah, the boys are well aware of the challenge ahead, off the back of a short turn around. I’m sure the boys will prepare really well for it.” News, results and expert analysis from the weekend of sport sent every Monday. Sign up for our Sport newsletter . Save Log in , register or subscribe to save articles for later. License this article Wallabies Australian rugby World Rugby Jonathan Drennan is a sports reporter for the Sydney Morning Herald. Most Viewed in Sport Loading
Discover what career Laura Bozzo studied at UNFV and what profession she pursued in VenezuelaSusan Estrich: A broken health system in the U.S.With more than half of the 16 teams still mathematically alive to make the conference championship game, the Big 12 will command a lot of attention in the final week of the regular season. No. 14 Arizona State and No. 17 Iowa State would play for the Big 12 title and likely College Football Playoff spot on Dec. 7 if they both win Saturday and there's a four-way tie for first place. There are seven other teams that begin this week with hopes, slim in most cases, of getting into the game at AT&T Stadium in Arlington, Texas. Last week it was No. 19 BYU and No. 23 Colorado that had the inside track to the championship game. Arizona State beat the Cougars and Kansas knocked off the Buffaloes, and here we are. "Everybody counted us out, I think, two weeks ago," Iowa State coach Matt Campbell said after his team beat Utah 31-28. "We didn't flinch. We didn't waver. And we just keep fighting." The Cyclones were national darlings the first half of the season as they won seven straight games to match the best start in program history. Back-to-back losses to Texas Tech and Kansas followed. Now they've won two straight heading into "Farmageddon," their rivalry game against Kansas State at home. "Right now they've got the pen and they continue to write the story," Campbell said of his players, "and I hope they will continue to write it the way they've got the ability to write it. Unwavering. Tough, mentally tough, physically tough. This group has stood for it every step of the way." Arizona State has been an even better story than the Cyclones. The Sun Devils have six more wins than they did last season, when they went 3-9. They were picked to finish last in their first year in the Big 12. They'll go for their fifth straight victory when they play at Arizona on Saturday. "These guys came off no momentum and everybody doubting them, and everybody is still doubting them. That's what makes this special," second-year coach Kenny Dillingham said. "Hopefully the expectations become higher. I don't know if there's a way we can exceed expectations more than we're exceeding them right now." Checking in on five of the Top 25: The Ducks were idle Saturday after clinching a spot in the Big Ten championship game with their win at Wisconsin on Nov. 16. Oregon can go 12-0 in the regular season for the first time since 2010 if it beats Washington at home this week. Oregon's only two losses last season came against the Huskies, both decided by three points. The first was a top-10 matchup in the regular season and the second was a top-five matchup in the Pac-12 championship game. The Ducks are 19 1/2-point favorites this time, according to BetMGM Sportsbook. The Buckeyes' showdown with upstart Indiana combined with Michigan's dropoff after winning the national championship have lowered the volume on this week's meeting with the Wolverines at the Horseshoe. If Michigan beats Ohio State a fourth straight time and it keeps the Buckeyes out of the Big Ten championship game and playoff ... well, there'll be lots of noise in Columbus then. The Lone Star Showdown returns to the gridiron for the first time since 2011, when Texas and Texas A&M were in the Big 12. The Longhorns head to No. 20 Texas A&M on a four-game win streak. The Aggies have lost two of three after Saturday's four-overtime loss at Auburn. The winner advances to the Southeastern Conference championship game against Georgia. The Broncos are tied with Notre Dame for the second-longest active win streak, at nine games, and they seem to have adopted a survive-and-advance mantra. They trailed 23-point underdog Wyoming in the fourth quarter before winning 17-13 and clinching a spot in the Mountain West championship game. They won their previous game, 42-21 against San Jose State, but didn't pull away until the fourth quarter. Two weeks ago they beat a three-win Nevada team 28-21. Just when you think Illinois is about to cash in for the season, they do what they did against Rutgers. The Illini were down 31-30 when they lined up for a 58-yard field goal with 14 seconds left. Ethan Moczulski missed. But wait. Rutgers called timeout before the snap, and Bret Bielema thought better of trying another kick and sent his offense back on the field. Luke Altmyer passed to Pat Bryant for the winning 40-yard touchdown. The Illini won't play for the Big Ten title, but they have a chance for nine wins and a nice bowl. Ohio State played in three of the five regular-season top-five matchups and won three of them. The Buckeyes lost to Oregon and beat Penn State and Indiana. ... Kansas' 37-21 win over Colorado made the Jayhawks the first FBS team with a losing record to beat three straight Top 25 opponents. The Jayhawks, who were 2-6 a month ago, will be bowl eligible if they win at Baylor. ... Nebraska ended the longest power conference bowl drought with its 44-25 win over Wisconsin. The Cornhuskers haven't played in a bowl since 2016.